AUS
NZ
UK
CA
USA
IND
Healthcare
Why Did Thrivent Financial Reduce Its Stake in Humana Inc. (NYSE:HUM)?
March 21, 2025 03:11 AM AEDT| By Team Kalkine MediaHeadlines,Thrivent Financial for Lutherans lowered its position in Humana Inc. during the fourth quarter.,Several institutional firms adjusted their holdings in the insurance provider.,Over 90% of Humana’s stock is held by institutional investors.,Th...
Why Did Institutional Investors Increase Their Holdings in Humana Inc. (NYSE:HUM)?
March 21, 2025 02:05 AM AEDT| By Team Kalkine MediaHeadlines,Institutional investors expanded their positions in Humana Inc. during recent quarters.,The company remains a key player in the health insurance sector, attracting significant institutional interest.,Multiple large firms adjusted their hold...
Can BioNTech's Institutional Momentum Propel Biotech Breakthroughs?
March 20, 2025 07:28 PM AEDT| By Team Kalkine MediaHighlights,Institutional entities significantly increased their positions in BioNTech (NASDAQ:BNTX).,Market evaluations from financial professionals remain favorable.,BioNTech continues its commitment to innovative therapies for cancer and infectious...
Can BioNTech Redefine Medical Breakthroughs in Today's Dynamic Industry?
March 20, 2025 06:28 PM AEDT| By Team Kalkine MediaHighlights,Extensive research and development drives cutting-edge medical treatments.,BioNTech (NASDAQ:BNTX) contributes to global health improvements through scientific innovation.,The biotechnology sector thrives on rigorous scientific methods and...
How Is Halozyme Therapeutics (NASDAQ:HALO) Navigating Market Trends?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,PNC Financial Services Group Inc. adjusted its stake in Halozyme Therapeutics, reflecting a shift in market activity.,Institutional investors maintain significant holdings, with multiple firms increasing their positions.,The company contin...
How Is Embecta Corp. (NASDAQ:EMBC) Navigating the Medical Device Industry?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors show varied interest in Embecta Corp., with some reducing and others increasing their holdings.,The company maintains dividend distributions, reflecting financial stability.,Embecta operates in the medical device se...
How Is Simulations Plus (NASDAQ:SLP) Expanding Its Role in Drug Development?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors have significantly expanded their positions in Simulations Plus.,The company specializes in software solutions for drug discovery and development.,Simulations Plus continues to see engagement from key financial enti...
Is Nurix Therapeutics (NASDAQ:NRIX) Positioned for Market Growth?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors have increased their holdings in Nurix Therapeutics.,Nurix Therapeutics continues to develop innovative therapies targeting cancer and autoimmune diseases.,Strategic adjustments by key stakeholders highlight the com...
How Is BridgeBio Pharma (NASDAQ: BBIO) Advancing Genetic Disease Treatments?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investments in BridgeBio Pharma have significantly increased in recent months.,The company continues to advance clinical programs for genetic diseases and oncology.,BridgeBio Pharma’s research-driven approach has attracted gr...
How Is Cross Country Healthcare (NASDAQ:CCRN) Positioned in the Healthcare Staffing Sector?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investment shifts have altered the ownership structure of Cross Country Healthcare.,Several hedge funds have acquired new stakes, increasing institutional holdings.,Cross Country Healthcare continues to operate as a key provi...
How Is Insmed (NASDAQ:INSM) Positioning Itself for Market Growth?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Proficio Capital Partners LLC has taken a noteworthy position in Insmed Incorporated.,Institutional investors have adjusted their holdings, signaling continued interest in the biopharmaceutical company.,Insmed maintains a strong financial...
Is Corcept Therapeutics (NASDAQ:CORT) on Track for Market Expansion?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors have shown increased interest in Corcept Therapeutics, with notable acquisitions in recent months.,The company maintains strong market performance, supported by its diversified drug development pipeline.,Liquidity r...
How Is Ascendis Pharma (NASDAQ:ASND) Advancing in the Biotech Industry?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Proficio Capital Partners LLC has acquired a substantial stake in Ascendis Pharma.,The company continues to advance in the biotechnology sector with an expanding clinical pipeline.,Ascendis Pharma maintains steady market positioning, suppo...
How Does BioLife Solutions (NASDAQ:BLFS) Engage in the Life Sciences Industry?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Steward Partners Investment Advisory LLC acquired new shares of BioLife Solutions, reflecting institutional activity in the company.,BioLife Solutions reported earnings per share above expectations, alongside steady revenue growth.,The com...
How Is Avanos Medical (NYSE:AVNS) Expanding Its Presence in the Healthcare Sector?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Victory Capital Management adjusts its stake in Avanos Medical, reflecting institutional engagement.,Various institutional entities, including Quarry LP and KBC Group NV, modified their holdings in Avanos Medical.,The company continues to...
How Is Dr. Reddy’s Laboratories (NYSE:RDY) Enhancing Its Pharmaceutical Offerings?
March 20, 2025 06:00 PM AEDT| By Team Kalkine MediaHighlights,Atria Investments Inc. acquired a stake in Dr. Reddy’s Laboratories, contributing to market engagement.,Institutional adjustments by firms such as Natixis Advisors LLC and POM Investment Strategies LLC reflect active participation.,Dr. Red...
Is Alvotech Transforming Biosimilar Treatments in Healthcare?
March 20, 2025 05:20 PM AEDT| By Team Kalkine MediaHighlights:,Alvotech (NASDAQ:ALVO) has observed increased short interest, reflecting active market engagement.,Institutional investments from entities such as BNP Paribas and Invesco Ltd. have notably risen.,Biosimilar programs including AVT02, AVT04...
Could Co-Diagnostics Reshape Molecular Testing?
March 20, 2025 05:20 PM AEDT| By Team Kalkine MediaHighlights:,Negative earnings per share of ($0.34) with revenue around $0.38 million,Stock opened at $0.47, spanning a year-low of $0.43 to a high of $2.23,Focus on molecular diagnostics, featuring the Co-Dx PCR platform,Co-Diagnostics (NASDAQ:CODX)...
Will BiomX Transform Microbiome Therapeutics?
March 20, 2025 05:20 PM AEDT| By Team Kalkine MediaHighlights,BiomX is scheduled to announce its quarterly earnings before market open later this month.,The company’s stock experienced a modest percentage gain at opening at a value in the lower price range.,The clinical-stage firm focuses on microbio...
Is BioSyent’s Financial Position Reflecting Stability In The Market?
March 20, 2025 04:29 PM AEDT| By Team Kalkine MediaIs BioSyent’s Financial Position Reflecting Stability in the Market?
